In situ gellable oxidized citrus pectin for localized delivery of anticancer drugs and prevention of homotypic cancer cell aggregation.
Takei
Takayuki
T
Department of Chemical Engineering, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0385, Japan. takei@chem-eng.kyushu-u.ac.jp
Sato
Mitsunobu
M
Ijima
Hiroyuki
H
Kawakami
Koei
K
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002449:Cell Aggregation / Q000187:drug effects; D045744:Cell Line, Tumor; D002957:Citrus; D004317:Doxorubicin / Q000008:administration & dosage; D016503:Drug Delivery Systems / Q000379:methods*; D005782:Gels / Q000737:chemistry; D006801:Humans; D020100:Hydrogels / Q000737:chemistry / Q000627:therapeutic use*; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology*; D010084:Oxidation-Reduction; D010368:Pectins / Q000737:chemistry / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D005782:Gels; D020100:Hydrogels; D004317:Doxorubicin; D010368:Pectins